AVITA Medical Stock (NASDAQ: RCEL) stock price, news, charts, stock research, profile.
Open | $9.810 |
Close | $9.380 |
Volume / Avg. | 227.564K / 214.407K |
Day Range | 9.340 - 9.880 |
52 Wk Range | 9.162 - 21.704 |
Market Cap | $243.442M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 17 |
Short Interest | 2.84% |
Days to Cover | 6.1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of AVITA Medical (NASDAQ: RCEL) through any online brokerage.
Other companies in AVITA Medical’s space includes: Adverum Biotechnologies (NASDAQ:ADVM), Inovio Pharmaceuticals (NASDAQ:INO), Adaptimmune Therapeutics (NASDAQ:ADAP), RAPT Therapeutics (NASDAQ:RAPT) and Lineage Cell Therapeutics (AMEX:LCTX).
The latest price target for AVITA Medical (NASDAQ: RCEL) was reported by BTIG on Thursday, April 11, 2024. The analyst firm set a price target for 0.00 expecting RCEL to fall to within 12 months (a possible -100.00% downside). 17 analyst firms have reported ratings in the last year.
The stock price for AVITA Medical (NASDAQ: RCEL) is $9.47 last updated April 17, 2024 at 7:58 PM EDT.
There are no upcoming dividends for AVITA Medical.
AVITA Medical’s Q1 earnings are confirmed for Monday, May 13, 2024.
There is no upcoming split for AVITA Medical.
AVITA Medical is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.